The Leadership Conference Responds to Preservation of Access to Mifepristone, Demands Further Protections for Nationwide Abortion Access

FOR IMMEDIATE RELEASE
Contact: Mattie Goldman, [email protected] 

WASHINGTON — Maya Wiley, president and CEO of The Leadership Conference on Civil and Human Rights, released the following statement on the Supreme Court’s decision in FDA v. Alliance for Hippocratic Medicine:

“Today, people who need a proven safe and effective abortion and miscarriage care drug can still get it. With the Supreme Court’s ruling, people can continue to access mifepristone, which more than 5 million people have used over the two decades since the FDA approved the drug. Anti-abortion activists brought this baseless case seeking to deprive people from accessing this scientifically proven medication based solely on their own personal beliefs they wish to impose on others. The Court has rightly recognized that the plaintiffs lacked sufficient standing and failed to demonstrate that this meritless case was anything more than an attack on abortion access nationwide. We are relieved the Court recognized that they had no standing to sue because they were not harmed by others receiving this medicine. Given the harmful Dobbs decision in 2022 that took away our constitutional right to abortion, this decision matters. We also know that this is not the end of their attacks on our rights and access to abortion care. 

“Despite the relief of today’s decision, we cannot ignore the Court’s ongoing ethics issues and past cases that threaten to further erode our hard won civil rights, including reversing the fundamental right to abortion and the recent decision to uphold racial gerrymandering in South Carolina. In the face of countless attacks from the extremist few against our civil rights, we continue to work in coalition with leaders in the reproductive and economic justice spaces to fight for abortion access for everyone. We deserve a thriving multiracial democracy and a Court that protects all of our civil and human rights.”

The Leadership Conference joined an amicus brief in FDA v. Alliance for Hippocratic Medicine, which is available here. We also published an explainer ahead of oral arguments in the case, which is available here.

The Leadership Conference on Civil and Human Rights is a coalition charged by its diverse membership of more than 240 national organizations to promote and protect the rights of all persons in the United States. The Leadership Conference works toward an America as good as its ideals. For more information on The Leadership Conference and its member organizations, visit www.civilrights.org.

###